688331 RemeGen Co., Ltd.
- 33.14
- -0.42-1.25%
About RemeGen Co., Ltd. Company
The company was co-founded in 2008 by Yantai Rongchang Pharmaceutical Co., Ltd., led by Mr. Wang Weidong, and American scientist Dr. Fang Jianmin. The company is committed to discovering, developing, producing and commercializing first-in-class and best-in-class biopharmaceuticals, and has created a number of new biopharmaceuticals with significant clinical value for major diseases such as autoimmunity, oncology, and ophthalmology. The company is an innovative biopharmaceutical company with a global perspective. Since its establishment, it has focused on the field of therapeutic antibody drugs such as antibody drug conjugates (ADC), antibody fusion proteins, monoclonal antibodies and double antibodies. Main products: titasip, verdicitumab, RC28, RC88, RC98, RC108, RC118, RC148, RC198, etc.
Company Profile
Company Executives
- Name
- Position
- Salary
- weidong wang
- Chairman, Executive Director
- 2.87M
- ruyi he
- Executive Director, Core Technical Personnel
- --
- jianmin fang
- Executive Director, General Manager, Core Technical Personnel, Chief Scientific Officer
- 8.14M
- jian lin
- Executive Director
- 847.70K
- liqiang wang
- Non-executive Directors
- --
- xiaodi su
- Non-executive Directors
- --
- xianjing hao
- Independent Directors
- 300.00K
- yunjin chen
- Independent Directors
- 300.00K
- lan ma
- Independent Directors
- 300.00K
- qingkai wen
- Board Secretary
- 2.01M
- wei liang
- Securities Affairs Representative
- --
- guangke ren
- Chairman of the Supervisory Board, Shareholders' Representatives and Supervisors
- 967.00K
- yupeng li
- Shareholders' Representatives and Supervisors
- --
- shaojing tong
- Chief Financial Officer, Joint Company Secretary
- 1.25M
- zhuanglin li
- Employee Supervisors
- 2.18M
Analysis
Price Target
No Data
No Data